Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturers:
|
Eviplera Emtricitabine 200mg Rilpivirine hydrochloride 27.5mg equivalent to Rilpivirine free base 25mg Tenofovir disoproxil fumarate 300mg Film coated tablet Gilead Sciences (NZ) Patheon Inc, Ontario, Canada Gilead Sciences UC, County Cork, Ireland
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturers:
|
Virasolve Benzalkonium chloride 0.5%w/w Idoxuridine 0.5%w/w Lidocaine hydrochloride monohydrate 2%w/w Topical cream Valeant Pharmaceuticals New Zealand Limited Probiotec Pharma Pty Limited, Melbourne, Australia Ensign Laboratories Pty Limited, Melbourne, Australia
|
Dated this 15th day of January 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).